Publication Author: Sullivan_Sean

• International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study.

  Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E; BOLD Collaborative Research Group. International variation in the prevalence of COPD

  rakerr2

  September 1, 2007

• Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices–budget impact analysis.

  Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, Orlewska E, Watkins J, Trueman P. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices–budget impact analysis. Value Health.

  rakerr2

  September 1, 2007

• Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease.

  Chen H, Gould MK, Blanc PD, Miller DP, Kamath TV, Lee JH, Sullivan SD; TENOR Study Group. Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol. 2007 Aug;120(2):396-402. Epub 2007 Jun 11.

  rakerr2

  August 1, 2007

• Cost-effectiveness of peginterferon alpha-2a compared with lamivudine treatment in patients with HBe-antigen-positive chronic hepatitis B in the United Kingdom.

  Veenstra DL, Sullivan SD, Dusheiko GM, Jacobs M, Aledort JE, Lewis G, Patel KK. Cost-effectiveness of peginterferon alpha-2a compared with lamivudine treatment in patients with HBe-antigen-positive chronic hepatitis B in the United Kingdom. Eur J Gastroen

  rakerr2

  August 1, 2007

• Quality of clinical and economic evidence in dossier formulary submissions.

  Colmenero F, Sullivan SD, Palmer JA, Brauer CA, Bungay K, Watkins J, Neumann PJ. Quality of clinical and economic evidence in dossier formulary submissions. Am J Manag Care. 2007 Jul;13(7):401-7.

  rakerr2

  July 1, 2007

• The cost-effectiveness of the management of acute sinusitis.

  Anzai Y, Jarvik JG, Sullivan SD, Hollingworth W. The cost-effectiveness of the management of acute sinusitis. Am J Rhinol. 2007 Jul-Aug;21(4):444-51.

  rakerr2

  July 1, 2007

• Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patients.

  Sullivan SD, Wenzel SE, Bresnahan BW, Zheng B, Lee JH, Pritchard M, Kamath TV, Weiss ST; TENOR Study Group. Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patients. Allergy. 2007 Jun;62(6):655-60.

  rakerr2

  June 1, 2007

• The cost of treating ribavirin-induced anemia in hepatitis C: the impact of using recombinant human erythropoietin.

  Devine EB, Cross JT, Kowdley KV, Sullivan SD. The cost of treating ribavirin-induced anemia in hepatitis C: the impact of using recombinant human erythropoietin. Curr Med Res Opin. 2007 Jun;23(6):1463-72. Epub 2007 May 17.

  rakerr2

  June 1, 2007

• Characterization of prescribing errors in an internal medicine clinic.

  Devine EB, Wilson-Norton JL, Lawless NM, Hansen RN, Hazlet TK, Kelly K, Hollingworth W, Blough DK, Sullivan SD. Characterization of prescribing errors in an internal medicine clinic. Am J Health Syst Pharm. 2007 May 15;64(10):1062-70.

  rakerr2

  May 15, 2007

• Agreement between caregiver reported healthcare utilization and administrative data for children with asthma.

  Lee TA, Fuhlbrigge AL, Sullivan SD, Finkelstein JA, Inui TS, Lozano P, Weiss KB. Agreement between caregiver reported healthcare utilization and administrative data for children with asthma. J Asthma. 2007 Apr;44(3):189-94.

  rakerr2

  April 1, 2007